ARTICLE | Company News
Abbott sales and marketing update
January 7, 2013 8:00 AM UTC
On Dec. 17, 2012, Abbott launched the Architect 2nd Generation Testosterone Assay in the U.S. for the quantitative determination of testosterone in human serum and plasma. The chemiluminescent microp...